Ocrevus Now Approved Website (Patient and HCP)




Brand: Ocrevus (ocrelizumab), Intravenous Infusion
Parent Company: Genentech
Drug Type: Prescription
Drug Category: Neurology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.ocrevus.com/patient.html
HCP Website: https://www.ocrevus.com/hcp.html